Published Medical Early Cancer Diagnosis RNA-nanoprobe for the identification of molecular biomarkers characterizing cancer in Circulating Tumour Cells (CTCs) from the blood of lung cancer patients. By University of Strathclyde
Published Medical IKK-Alpha Cancer Treatment Scientists at Strathclyde have developed the first reported potent and selective IKK alpha inhibitors, and our lead compound has been shown to achieve 60% tumour growth inhibition By University of Strathclyde